In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds

References

• World Health Organization. World malaria report. 2018.
   Google Scholar
• Medicine for Malaria Venture. History of antimalarials. Available from: https://www.mmv.org/malaria-medicines/history-antimalarials. Accessed 320, 2020.
   Google Scholar
• World Health Organization. Artemisinin resistance and artemisinin-based combination therapy efficacy (Status report – August 2018). August, 2018.
   Google Scholar
• Medicines for Malaria venture. Defeating malaria together.; 2017.
   Google Scholar
• BurrowsJN, DuparcS, GutteridgeWE, et al. New developments in anti malarial target candidate and product profiles. Malar J. 2017:1–29. doi:10.1186/s12936-016-1675-x.28049519
   PubMed Web of Science ®Google Scholar
• SrivastavaA, PhilipN, HughesKR, et al. Stage-specific changes in plasmodium metabolism required for differentiation and adaptation to different host and vector environments. PLoS Pathog. 2016;12(12):1–30. doi:10.1371/journal.ppat.1006094
   Web of Science ®Google Scholar
• LamourSD, StraschilU, SaricJ, DelvesMJ. Changes in metabolic phenotypes of Plasmodium falciparum in vitro cultures during gametocyte development. Malar J. 2014;13(1):1–10. doi:10.1186/1475-2875-13-46824383426
   PubMed Web of Science ®Google Scholar
• SindenRE. Developing transmission-blocking strategies for malaria control. PLoS Pathog. 2017;13(7):1–12. doi:10.1371/journal.ppat.1006336
   Web of Science ®Google Scholar
• OuédraogoAL, BastiaensGJH, TionoAB, et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis. 2015;60(3):357–365. doi:10.1093/cid/ciu79725414262
   PubMed Web of Science ®Google Scholar
• Van VoorhisWC, AdamsJH, AdelfioR, et al. Open source drug discovery with the malaria box compound collection for neglected diseases and beyond. PLoS Pathog. 2016;12(7):1–23. doi:10.1371/journal.ppat.1005763
   Web of Science ®Google Scholar
• MaleboHM, WenzlerT, CalM, et al. Anti-protozoal activity of aporphine and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels) Setten & Maas (Annonaceae). BMC Complement Altern Med. 2013;13(1). doi:10.1186/1472-6882-13-48
   PubMed Web of Science ®Google Scholar
• MarvertiG, LigabueA, LombardiP, et al. Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and-resistant human ovarian cancer cells. Int J Oncol. 2013;43(4):1269–1280. doi:10.3892/ijo.2013.204523903781
   PubMed Web of Science ®Google Scholar
• CreekDJ, ChuaHH, CobboldSA, NijagalB, MacraeJI, DickermanBK. Metabolomics-based screening of the malaria box reveals both novel and established mechanisms of action. Antimicrob Agents Chemother. 2016;60(11):6650–6663. doi:10.1128/AAC.01226-1627572396
   PubMed Web of Science ®Google Scholar
• UrsuO, RayanA, GoldblumA, OpreaTI. Understanding drug-likeness. Wiley Interdiscip Rev Comput Mol Sci. 2011;1(5):760–781. doi:10.1002/wcms.52
   Web of Science ®Google Scholar
• LipinskiCA, LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64(SUPPL):4–17. doi:10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• TaoW, XuX, WangX, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013;145(1):1–10. doi:10.1016/j.jep.2012.09.05123142198
   PubMed Web of Science ®Google Scholar
• XuX, ZhangW, HuangC, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13(6):6964–6982. doi:10.3390/ijms1306696422837674
   PubMed Web of Science ®Google Scholar
• FloydDM, SteinP, WangZ, et al. Hit-to-lead studies for the antimalarial tetrahydroisoquinoline carboxanilides. J Med Chem. 2016;59(17):7950–7962. doi:10.1021/acs.jmedchem.6b0075227505686
   PubMed Web of Science ®Google Scholar
• RishtonGM. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today. 2003;8(2):86–96. doi:10.1016/S135964460202572212565011
   PubMed Web of Science ®Google Scholar
• SpangenbergT, BurrowsJN, KowalczykP, McDonaldS, WellsTNC, WillisP. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One. 2013;8(6):e62906. doi:10.1371/journal.pone.006290623798988
   PubMed Web of Science ®Google Scholar
• TragerW, JensenJ. Human malaria parasites in continuous culture. J Parasitol. 2005;91(3):484–486. doi:10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;216108535
   PubMed Web of Science ®Google Scholar
• MaklerMT, RiesJM, WilliamsJA, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993;48(6):739–741. doi:10.4269/ajtmh.1993.48.7398333566
   PubMed Web of Science ®Google Scholar
• D’AlessandroS, SilvestriniF, DecheringK, et al. A plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. J Antimicrob Chemother. 2013;68(9):2048–2058. doi:10.1093/jac/dkt16523645588
   PubMed Web of Science ®Google Scholar
• D’AlessandroS, CamardaG, CorbettY, et al. A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays. J Antimicrob Chemother. 2016;71(5):1148–1158. doi:10.1093/jac/dkv49326888912
   PubMed Web of Science ®Google Scholar
• TapanelliS, ChianeseG, LucantoniL, YerbangaRS, HabluetzelA, Taglialatela-ScafatiO. Transmission blocking effects of neem (Azadirachta indica) seed kernel limonoids on Plasmodium berghei early sporogonic development. Fitoterapia. 2016;114:122–126. doi:10.1016/j.fitote.2016.09.00827642038
   PubMed Web of Science ®Google Scholar
• LucantoniL, SilvestriniF, SignoreM, et al. A simple and predictive phenotypic high content imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds. Sci Rep. 2015;5(July):1–14. doi:10.1038/srep16414
   Web of Science ®Google Scholar
• SwannJ, CoreyV, SchererCA, et al. High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria. ACS Infect Dis. 2016;2(4):281–293. doi:10.1021/acsinfecdis.5b0014327275010
   PubMed Web of Science ®Google Scholar
• PlouffeDM, WreeM, DuAY, et al. High-throughput assay and discovery of small molecules that interrupt malaria transmission. Cell Host Microbe. 2016;19(1):114–126. doi:10.1016/j.chom.2015.12.00126749441
   PubMed Web of Science ®Google Scholar
• RueckerA, MathiasDK, StraschilU, et al. A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. Antimicrob Agents Chemother. 2014;58(12):7292–7304. doi:10.1128/AAC.03666-1425267664
   PubMed Web of Science ®Google Scholar
• DuffyS, AveryVM. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J. 2013;12(1);408.24206914
   PubMed Web of Science ®Google Scholar
• DelvesM, Lafuente-MonasterioMJ, UptonL, et al. Fueling open innovation for malaria transmission-blocking drugs: hundreds of molecules targeting early parasite mosquito stages. Front Microbiol. 2019;10(September):1–10. doi:10.3389/fmicb.2019.0213430728808
   PubMed Web of Science ®Google Scholar